Christopher Richard Anzalone, Chief Executive Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 176,427 shares at $11.49 ($1.9M) on 2025-04-11, disclosed to the SEC on 2025-04-11.
Open-market sale of $1.9M ARWR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.93 | 35,305 | $351K | 18.6% |
| 2 | $9.93 | 35,305 | $351K | 18.6% |
| 3 | $10.75 | 3,400 | $37K | 1.9% |
| 4 | $11.76 | 1,617 | $19K | 1.0% |
| 5 | $10.87 | 50,000 | $544K | 28.8% |
| 6 | $11.49 | 50,800 |
| $584K |
| 31.0% |
| Total | $10.68 avg | 176,427 | $1.9M | 100% |
| Filing → |
| ARWR | SELL | 2025-12-23 | $3.5M | — | Filing → |
| ARWR | SELL | 2025-12-19 | $10.9M | — | Filing → |
| ARWR | SELL | 2025-12-16 | $24.6M | — | Filing → |